98%
921
2 minutes
20
Background: Walking, important for cardiovascular health and autonomic regulation, is often done on a treadmill.
Aim: This study compared the physiological responses of treadmill and virtual reality walking, focusing on their effects on the autonomic nervous system, recovery, and perceived exertion.
Methods: This study included 40 sedentary participants, assigned to a treadmill group (TG) or a virtual reality group (VRG). Both groups performed 20-minute treadmill walking, with the VRG additionally using the Wii Fit program. Autonomic assessments with the Polar H10 measured heart rate (HR), parasympathetic nervous system (PNS), sympathetic nervous system (SNS), stress index (SI), and the LF/HF ratio. At the same time, perceived exertion was assessed using the OMNI scale. Physiological responses were measured at baseline (T0), post exercise (T1), and at 10 (T2) and 30 minutes (T3) of recovery.
Results: The study showed significant differences in HR (P = 0.040) and LF/HF (P = 0.038) between T0-T1 in the TG. In the VRG, significant changes were found in HR (P = 0.016), SNS (P = 0.010), SI (P = 0.014), and LF/HF (P = 0.020) between T0-T1, with an additional difference in LF/HF at T0-T2 (P = 0.032). OMNI scores significantly differed at all time points (P < 0.05). No significant differences were found between groups in autonomic parameters or OMNI scores (P > 0.05).
Conclusion: Although perceived exertion was similar, the VR group showed greater SNS activation due to immersion, while recovery was identical for both methods. This understanding could contribute to developing rehabilitation strategies considering autonomic VR responses.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4103/njcp.njcp_121_25 | DOI Listing |
Alzheimers Res Ther
September 2025
Department of Neurology, Saarland University, Kirrberger Straße, 66421, Homburg/Saar, Germany.
Background: Alzheimer's disease (AD) patients and animal models exhibit an altered gut microbiome that is associated with pathological changes in the brain. Intestinal miRNA enters bacteria and regulates bacterial metabolism and proliferation. This study aimed to investigate whether the manipulation of miRNA could alter the gut microbiome and AD pathologies.
View Article and Find Full Text PDFJ Neuroeng Rehabil
September 2025
Institute for Neuromodulation and Neurotechnology, University Hospital and University of Tübingen, 72076, Tübingen, Germany.
Innovative technology allows for personalization of stimulation frequency in dual-site deep brain stimulation (DBS), offering promise for challenging symptoms in advanced Parkinson's disease (PD), particularly freezing of gait (FoG). Early results suggest that combining standard subthalamic nucleus (STN) stimulation with substantia nigra pars reticulata (SNr) stimulation may improve FoG outcomes. However, patient response and the optimal SNr stimulation frequency vary.
View Article and Find Full Text PDFBMC Ophthalmol
September 2025
Department of Ophthalmology, Institute of Medicine, Tribhuvan University, B.P Koirala Lions Centre For Ophthalmic Studies, Kathmandu, Nepal.
Background: To evaluate the ganglion cell complex thickness in patients taking oral hydroxychloroquine.
Methods: In this hospital-based, cross-sectional, non-interventional, comparative study, 87 eyes of 87 patients taking hydroxychloroquine were recruited. All the patients underwent complete ophthalmological evaluation along with dilated fundus examination.
J Mol Neurosci
September 2025
Department of Physiology, School of Medicine, Dokuz Eylul University, Izmir, Turkey.
The ketogenic diet (KD), a high-fat, low-carbohydrate regimen, has been shown to exert neuroprotective effects in various neurological models. This study explored how KD-alone or combined with antibiotic-induced gut microbiota depletion-affects cognition and neuroinflammation in aging. Thirty-two male rats (22 months old) were assigned to four groups (n = 8): control diet (CD), ketogenic diet (KD), antibiotics with control diet (AB), and antibiotics with KD (KDAB).
View Article and Find Full Text PDFNat Rev Cancer
September 2025
Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
Neurotoxicity is a common and potentially severe adverse effect from conventional and novel cancer therapy. The mechanisms that underlie clinical symptoms of central and peripheral nervous system injury remain incompletely understood. For conventional cytotoxic chemotherapy or radiotherapy, direct toxicities to brain structures and neurovascular damage may result in myelin degradation and impaired neurogenesis, which eventually translates into delayed neurodegeneration accompanied by cognitive symptoms.
View Article and Find Full Text PDF